Volume 16, Issue 15, Pages (August 2006)

Slides:



Advertisements
Similar presentations
Volume 27, Issue 6, Pages (September 2007)
Advertisements

María Dolores Vázquez-Novelle, Mark Petronczki  Current Biology 
A Novel Cofactor for p300 that Regulates the p53 Response
Volume 19, Issue 4, Pages (August 2005)
Volume 28, Issue 4, Pages (November 2007)
Multiple Tumor Suppressor Pathways Negatively Regulate Telomerase
Volume 14, Issue 4, Pages (May 2004)
Volume 41, Issue 5, Pages (March 2011)
Volume 19, Issue 4, Pages (August 2005)
Volume 18, Issue 2, Pages (August 2010)
Megan van Overbeek, Titia de Lange  Current Biology 
Volume 38, Issue 4, Pages (May 2010)
Volume 36, Issue 2, Pages (October 2009)
NRF2 Is a Major Target of ARF in p53-Independent Tumor Suppression
ASK1 Is Essential for JNK/SAPK Activation by TRAF2
Sherilyn Grill, Valerie M. Tesmer, Jayakrishnan Nandakumar 
Volume 17, Issue 3, Pages (February 2005)
Volume 4, Issue 4, Pages (April 1996)
Yongli Bai, Chun Yang, Kathrin Hu, Chris Elly, Yun-Cai Liu 
Communication with the Exon-Junction Complex and Activation of Nonsense-Mediated Decay by Human Upf Proteins Occur in the Cytoplasm  Guramrit Singh, Steffen.
Volume 130, Issue 4, Pages (August 2007)
Volume 38, Issue 4, Pages (May 2010)
Robert L.S Perry, Maura H Parker, Michael A Rudnicki  Molecular Cell 
Volume 149, Issue 4, Pages (May 2012)
Volume 27, Issue 6, Pages (September 2007)
Direct Interactions of OCA-B and TFII-I Regulate Immunoglobulin Heavy-Chain Gene Transcription by Facilitating Enhancer-Promoter Communication  Xiaodi.
Slicing-Independent RISC Activation Requires the Argonaute PAZ Domain
Volume 10, Issue 22, Pages (November 2000)
MCM9 Is Required for Mammalian DNA Mismatch Repair
Volume 123, Issue 2, Pages (October 2005)
Purification of Proteins Associated with Specific Genomic Loci
Maïlys A.S. Vergnolle, Stephen S. Taylor  Current Biology 
Volume 17, Issue 12, Pages (December 2016)
Volume 9, Issue 3, Pages (March 2002)
HDAC5, a Key Component in Temporal Regulation of p53-Mediated Transactivation in Response to Genotoxic Stress  Nirmalya Sen, Rajni Kumari, Manika Indrajit.
TRF2 Protects Human Telomeres from End-to-End Fusions
Volume 7, Issue 4, Pages (April 2001)
Volume 16, Issue 24, Pages (December 2006)
Volume 2, Issue 6, Pages (December 2012)
The DNA Damage Machinery and Homologous Recombination Pathway Act Consecutively to Protect Human Telomeres  Ramiro E. Verdun, Jan Karlseder  Cell  Volume.
Volume 56, Issue 5, Pages (December 2014)
Volume 12, Issue 2, Pages (August 2012)
MyoD Targets TAF3/TRF3 to Activate Myogenin Transcription
Ramiro E. Verdun, Laure Crabbe, Candy Haggblom, Jan Karlseder 
Purification of Human Telomerase Complexes Identifies Factors Involved in Telomerase Biogenesis and Telomere Length Regulation  Dragony Fu, Kathleen Collins 
Hus1 Acts Upstream of Chk1 in a Mammalian DNA Damage Response Pathway
Volume 17, Issue 1, Pages (January 2010)
Volume 17, Issue 22, Pages (November 2007)
Yi Tang, Jianyuan Luo, Wenzhu Zhang, Wei Gu  Molecular Cell 
A Dynamic Molecular Link between the Telomere Length Regulator TRF1 and the Chromosome End Protector TRF2  Benjamin R. Houghtaling, Leanora Cuttonaro,
Volume 20, Issue 5, Pages (March 2010)
TopBP1 Activates the ATR-ATRIP Complex
Volume 13, Issue 10, Pages (December 2015)
Volume 17, Issue 8, Pages (April 2007)
Volume 19, Issue 14, Pages (July 2009)
Volume 25, Issue 5, Pages (March 2007)
Dan Yu, Rongdiao Liu, Geng Yang, Qiang Zhou  Cell Reports 
Disruption of the Rag-Ragulator Complex by c17orf59 Inhibits mTORC1
Volume 25, Issue 10, Pages e8 (December 2018)
Volume 21, Issue 12, Pages (June 2011)
Fig. 1. Coilin interaction with the telomerase complex protein dyskerin is mediated by hTR. Coilin interaction with the telomerase complex protein dyskerin.
Antonio Porro, Sascha Feuerhahn, Joachim Lingner  Cell Reports 
Volume 16, Issue 16, Pages (August 2006)
The Human DiGeorge Syndrome Critical Region Gene 8 and Its D
Mahesh Ramamoorthy, Susan Smith  Cancer Cell 
PU.1 Expression Delineates Heterogeneity in Primary Th2 Cells
Volume 15, Issue 16, Pages (August 2005)
Volume 41, Issue 4, Pages (February 2011)
Volume 123, Issue 2, Pages (October 2005)
Yun-Gui Yang, Tomas Lindahl, Deborah E. Barnes  Cell 
Presentation transcript:

Volume 16, Issue 15, Pages 1551-1558 (August 2006) Telomere and Telomerase Modulation by the Mammalian Rad9/Rad1/Hus1 DNA- Damage-Checkpoint Complex  Sofia Francia, Robert S. Weiss, M. Prakash Hande, Raimundo Freire, Fabrizio d'Adda di Fagagna  Current Biology  Volume 16, Issue 15, Pages 1551-1558 (August 2006) DOI: 10.1016/j.cub.2006.06.066 Copyright © 2006 Elsevier Ltd Terms and Conditions

Figure 1 The 911 Complex Is a Novel Component of Human Telomeres (A) Chromatin immunoprecipitations were performed in HeLa cells by means of a panel of matched preimmune and immune sera raised against the individual factors HUS1, RAD9, or RAD1 (numbers in parentheses indicate individual immunized rabbits). DNA was spotted onto a membrane and sequentially hybridized with telomeric or Alu DNA probes. Values for percent of telomeric DNA immunoprecipated (first two columns) were calculated by dividing the ChIP signal by the signal for a known amount of input chromatin spotted directly onto the membrane. Values shown in the third column represent the calculated fold increase of the telomeric DNA signal of the immune over the preimmune sera immunoprecipitations upon normalization with the Alu DNA probe. Values shown in the far right column represent the ratio between values shown in the third column and those obtained in an identical set of immuoprecipitations with chromatin that was not crosslinked (data not shown). (B) In HeLa cells, antibodies against HUS1 and TRF1, a telomeric DNA binding protein, or against CENP-A, a centromeric-associated protein, preferentially immunoprecipitate telomeric or centromeric DNA, respectively. (C) 911 complex is associated with telomeric DNA independently from DNA replication and proliferation in HDFs. HDFs were synchronized by contact inhibition and subjected to ChIP as described above. Lack of DNA replication was monitored by BrdU incorporation (data not shown). Current Biology 2006 16, 1551-1558DOI: (10.1016/j.cub.2006.06.066) Copyright © 2006 Elsevier Ltd Terms and Conditions

Figure 2 Loss of Hus1 Leads to Telomere Shortening (A) Results from qFISH analysis of telomere length in primary MEFs obtained from two independent litters generated from heterozygous crosses are shown. One TFU (telomere fluorescence unit) corresponds to 1 kb of TTAGGG repeats. Results are shown for p-arm telomeres, q-arm telomeres, and all ends. Values are expressed as mean ± standard error. The mean value for each genotype is indicated in bold font. Histograms describe the frequency distribution of qFISH values for the three different genotypes. The horizontal axis shows the intensity of each signal, and the vertical axis shows the frequency of telomeres of a given length. (B) Results from telomere length analysis by flow-FISH of uncultured thymocytes are shown. Values are expressed in thousands of molecules of equivalent soluble fluorochrome (MESF). Values are reported next to their genotype. Thymocytes from Hus1flox/Δ1Lck-cre+ (conditional knockout), Hus1flox/Δ1Lck-cre− (control), Hus1+/floxLck-cre− (control), and Hus1+/floxLck-cre+ (control) experimental animals were analyzed. The mean value ± standard error for conditional Hus1 knockout and control samples is indicated in bold font. The statistical significance of telomere differences between genotypes is described by the calculated p values. Current Biology 2006 16, 1551-1558DOI: (10.1016/j.cub.2006.06.066) Copyright © 2006 Elsevier Ltd Terms and Conditions

Figure 3 The 911 Complex Is Associated with Catalytically Active Telomerase (A) FLAG antibody coimmunoprecipitates telomerase activity with 911 from 293T cells transiently transfected with FLAG-tagged Rad9, Rad1, and Hus1, as detected by TRAP assays. A specific competitor peptide, but not an equal amount of an unrelated one, abolished 911 binding to the beads as determined by immunoblotting (right) and strongly reduced immunoprecipitated TRAP activity. TRAP assays were performed on untreated or heat-treated samples. Each lane includes an internal control for PCR amplification. Fold increase relative to activity for beads alone is shown at the bottom. (B) Affinity-purified antibodies raised against the individual subunits of the 911 complex immunoprecipitate TRAP activity from HeLa cells. A RAD1 peptide against which the antibody was raised, but not an equal amount of an unrelated peptide, specifically competes for RAD1 binding as determined by immunoblotting (bottom) and reduces the amount of immunoprecipitated TRAP activity (top). (C) Antibodies raised against RPA34, RPA70, and ATR do not coimmunoprecipitate telomerase activity from HeLa cells. Successful immunoprecipitation of RPA34, RPA70, and ATR is demonstrated by immunoblotting (bottom). Current Biology 2006 16, 1551-1558DOI: (10.1016/j.cub.2006.06.066) Copyright © 2006 Elsevier Ltd Terms and Conditions

Figure 4 Lack of Hus1 Impairs In Vitro Telomerase Activity (A) Hus1 null cells have reduced telomerase activity compared to Hus1-expressing cells over a range of concentrations. Extracts were prepared from cells of the indicated genotype and subjected to analysis by TRAP assay. (B) Expression of a Hus1 cDNA in Hus1-deficient cells rescues telomerase activity defect. Hus1+/+p21−/− and Hus1Δ1n/Δ1np21−/− MEFs, stably expressing GFP or Hus1 from a retroviral vector, were subjected to TRAP analysis. (C) Expression of short interfering RNAs against HUS1 in human cells reduces telomerase activity. HeLa cells were infected with lentiviruses encoding GFP or shRNAs against HUS1, and the resulting extracts were subjected to TRAP analysis at the indicated times post selection. (D) Expression of short interfering RNAs against ATR in human cells does not affect telomerase activity. HeLa cells were transfected with siRNAs against GFP or ATR, and the resulting extracts were subjected to TRAP analysis. Reduced ATR expression was confirmed by indirect immunofluorescence analysis in which cells were stained with anti-ATR antiserum and DAPI (right). Current Biology 2006 16, 1551-1558DOI: (10.1016/j.cub.2006.06.066) Copyright © 2006 Elsevier Ltd Terms and Conditions